Deals & Cases
Schellenberg Wittmer advised Boehringer Ingelheim on its acquisition of Evax AG
25.08.2026
Schellenberg Wittmer advised Boehringer Ingelheim, one of the largest pharmaceutical companies, on the acquisition of Evax AG. Evax AG is a Swiss biotech company focused on equine health.